Diabetes and outcome of community-acquired pneumococcal bacteremia: A 10-year population-based cohort study

Diabetes Care

Volumn 27, Issue 1, 2004, Pages 70-76

  Thomsen, Reimar Wernich ^a   Hundborg, Heidi H ^a   Lervang, Hans Henrik ^a   Johnsen, Søren P ^a   Sørensen, Henrik T ^a   Schønheyder, Henrik C ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BACTEREMIA; COHORT ANALYSIS; COMMUNITY ACQUIRED PNEUMONIA; COMORBIDITY; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC ANGIOPATHY; DISEASE ASSOCIATION; FATALITY; FEMALE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOMES RESEARCH; REGISTER; SEX RATIO; STREPTOCOCCUS INFECTION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; COMMUNITY-ACQUIRED INFECTIONS; COMORBIDITY; DENMARK; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; MIDDLE AGED; PNEUMOCOCCAL INFECTIONS; REGISTRIES; TREATMENT OUTCOME;

EID: 1042268738     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.27.1.70     Document Type: Article

References (35)

1. Watanakunakorn C, Greifenstein A, Stroh K, Jarjoura DG, Blend D, Cugino A, Ognibene AJ: Pneumococcal bacteremia in three community teaching hospitals from 1980 to 1989. Chest 103:1152-1156, 1993
2. Afessa B, Greaves WL, Frederick WR: Pneumococcal bacteremia in adults: a 14-year experience in an inner-city university hospital. Clin Infect Dis 21:345-351, 1995
3. Kalin M, Örtqvist Å, Almela M, Aufwerber E, Dwyer R, Henriques B, Jorup C, Julander I, Marrie TJ, Mufson MA, Riquelme R, Thalme A, Torres A, Woodhead MA: Prospective study of prognostic factors in community-acquired bacteremic pneumococcal disease in 5 countries. J Infect Dis 182:840-847, 2000
4. King H, Aubert RE, Herman WH: Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 21:1414-1431, 1998
5. Joshi N, Caputo GM, Weitekamp MR, Karchmer AW: Infections in patients with diabetes mellitus. N Engl J Med 341:1906-1912, 1999
6. American Diabetes Association: Immunization and the prevention of influenza and pneumococcal disease in people with diabetes (Position Statement). Diabetes Care 23:109-111, 2000
7. Watkins PJ, Soler NG, Fitzgerald MG, Malins JM: Diabetic ketoacidosis during the influenza epidemic. BMJ 4:89-91, 1970
8. Delamaire M, Maugendre D, Moreno M, Le Golf MC, Allannic H, Genetet B: Impaired leucocyte functions in diabetic patients. Diabet Med 14:29-34, 1997
9. Koziel H, Koziel MJ: Pulmonary complications of diabetes mellitus: pneumonia. Infect Dis Clin North Am 9:65-96, 1995
10. Smith SA, Poland GA: Use of influenza and pneumococcal vaccines in people with diabetes. Diabetes Care 23:95-108, 2000
11. Austrian R, Gold J: Pneumococcal bacteremia with especial reference to bacteremic pneumococcal pneumonia. Ann Intern Med 60:759-76, 1964
12. Mufson MA, Kruss DM, Wasil RE, Metzger WI: Capsular types and outcome of bacteremic pneumococcal disease in the antibiotic era. Arch Intern Med 134:505-510, 1974
13. Gransden WR, Eykyn SJ, Phillips I: Pneumococcal bacteraemia: 325 episodes diagnosed at St. Thomas's Hospital. BMJ (Clin Res Ed) 290:505-508, 1985
14. Burman LA, Norrby R, Trollfors B: Invasive pneumococcal infections: incidence, predisposing factors, and prognosis. Rev Infect Dis 7:133-142, 1985
15. Schønheyder HC, Höjbjerg T: The impact of the first notification of positive blood cultures on antibiotic therapy: a one-year survey. APMIS 103:37-44, 1995
16. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM: CDC definitions for nosocomial infections, 1988. Am J Infect Control 16:128-140, 1988
17. Friedman ND, Kaye KS, Stout JE, McGarry SA, Trivette SL, Briggs JP, Lamm W, Clark C, MacFarquhar J, Walton AL, Reller LB, Sexton DJ: Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med 137:791-797, 2002
18. Prag J, Jensen J, Lebech K: Colorbact, a visually read blood culture system using darkening of haemoglobin in aerobic blood cultures as an early growth indicator, compared with Bactec 6A and 7A. APMIS 99:1089-1095, 1991
19. Kristensen B, Højbjerg T, Schønheyder HC: Rapid immunodiagnosis of streptococci and enterococci in blood cultures. APMIS 109:284-288, 2001
20. Nielsen GL, Sørensen HT, Zhou W, Steffensen FH, Olsen J: The Pharmacoepidemiologic Prescription Database of North Jutland: a valid tool in pharmacoepidemiological research. Int J Risk Safety Med 10:203-205, 1997
21. Andersen TF, Madsen M, Jørgensen J, Mellemkjær L, Olsen JH: The Danish National Hospital Register: a valuable source of data for modern health sciences. Dan Med Bull 46:263-268, 1999
22. World Health Organization: Diabetes Mellitus: Report of a WHO Study Group. Geneva, World Health Org., 1985 (Tech. Rep. Ser., no. 727)
23. DECODE Study Group on behalf of the European Diabetes Epidemiology Study Group: Will new diagnostic criteria for diabetes mellitus change phenotype of patients with diabetes? Reanalysis of European epidemiological data. BMJ 317:371-375, 1998
24. Charlson ME, Pompei P, Ales KL, MacKenzie CR: A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373-383, 1987
25. Deyo RA, Cherkin DC, Ciol MA: Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 45:613-619, 1992
26. de Groot V, Beckerman H, Lankhorst GJ, Bouter LM: How to measure comorbidity: a critical review of available methods. J Clin Epidemiol 56:221-229, 2003
27. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis: the ACCP/SCCM Consensus Conference Committee: American College of Chest Physicians/Society of Critical Care Medicine. Chest 101:1644-1655, 1992
28. Bryan CS, Reynolds KL, Metzger WT: Bacteremia in diabetic patients: comparison of incidence and mortality with nondiabetic patients. Diabetes Care 8:244-249, 1985
29. Leibovici L, Samra Z, Konisberger H, Kalter-Leibovici O, Pitlik SD, Drucker M: Bacteremia in adult diabetic patients. Diabetes Care 14:89-94, 1991
30. Carton JA, Maradona JA, Nuno FJ, Fernandez-Alvarez R, Perez-Gonzalez F, Asensi V: Diabetes mellitus and bacteraemia: a comparative study between diabetic and non-diabetic patients. Eur J Med 1:281-287, 1992
31. Nielsen GL, Sorensen HT, Pedersen AB, Sabroe S: Analyses of data quality in registries concerning diabetes mellitus: a comparison between a population based hospital discharge and an insulin prescription registry. J Med Syst 20:1-10, 1996
32. Moss M, Guidot DM, Steinberg KP, Duhon GF, Treece P, Wolken R, Hudson LD, Parsons PE: Diabetic patients have a decreased incidence of acute respiratory distress syndrome. Crit Care Med 28:2187-2192, 2000
33. van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R: Intensive insulin therapy in the critically ill patients. N Engl J Med 345:1359-1367, 2001
34. Liappis AP, Kan VL, Rochester CG, Simon GL: The effect of statins on mortality in patients with bacteremia. Clin Infect Dis 33:1352-1357, 2001
35. Riahi S, Fonager K, Toft E, Hvilsted-Rasmussen L, Bendsen J, Johnsen SP, Sørensen HT: Use of lipid-lowering drugs during 1991-98 in Northern Jutland, Denmark. Br J Clin Pharmacol 52:307-311, 2001